Insulin Resistance Prevents Healthy Weight Loss

Weight loss is often portrayed as a simple equation of calories in versus calories out. However, for many individuals, particularly those with insulin resistance, this oversimplification fails to capture the complex hormonal and metabolic reality that governs fat storage and energy use. Insulin resistance is a physiological condition in which the body's cells become less responsive to the hormone insulin, leading to higher circulating levels of both insulin and glucose. This state not only predisposes individuals to type 2 diabetes and cardiovascular disease but also creates significant challenges in achieving and maintaining weight loss.

Understanding Insulin and Its Role in Metabolism

Insulin is a key anabolic hormone responsible for facilitating glucose uptake into cells, primarily muscle, liver, and fat tissue. When carbohydrates are consumed and broken down into glucose, insulin is released from the pancreas to help shuttle glucose into cells for immediate energy or storage (Petersen and Shulman, 2018). In a healthy individual, insulin levels rise postprandially and return to baseline once glucose is cleared. However, in insulin resistance, cells no longer respond efficiently to insulin, resulting in hyperinsulinemia (high insulin levels) as the body attempts to compensate (Czech, 2017).

The Link Between Insulin Resistance and Weight Gain

High insulin levels are inherently lipogenic—that is, they promote fat storage. Insulin inhibits hormone-sensitive lipase, an enzyme required for the breakdown of stored triglycerides in adipose tissue, while simultaneously stimulating lipoprotein lipase, which facilitates the uptake of fat into adipose cells (Boden, 2008). In the context of insulin resistance, persistently elevated insulin levels mean the body remains in a "fat-storage mode" and resists mobilising fat for energy.

Moreover, hyperinsulinemia shifts energy storage towards visceral fat accumulation, the metabolically active fat stored around organs, which is associated with greater inflammatory signalling and worsened insulin resistance, creating a self-perpetuating cycle (Després, 2012).

Why Weight Loss Is More Difficult with Insulin Resistance

1. Impaired Fat Mobilisation

One of the primary mechanisms that hinders weight loss in individuals with insulin resistance is the suppression of lipolysis—the process of breaking down stored fat for energy. Elevated insulin blocks this process, meaning that even in a caloric deficit, the body is less likely to tap into fat reserves for fuel (Kashyap and DeFronzo, 2007). Instead, it may turn to lean tissue or circulating glucose, which contributes to muscle loss rather than fat loss.

2. Increased Hunger and Reduced Satiety

Insulin has direct effects on the central nervous system, particularly in the hypothalamus, where it interacts with neuropeptides that regulate hunger. In insulin-resistant individuals, insulin's appetite-suppressing effects are diminished (Benedict et al., 2003). Additionally, insulin resistance is associated with leptin resistance—leptin being the hormone responsible for signalling satiety to the brain (Myers et al., 2010). This hormonal milieu leads to increased hunger, reduced fullness, and difficulty adhering to caloric restriction.

3. Altered Substrate Utilisation

Healthy individuals have metabolic flexibility—the ability to switch between using carbohydrates and fats as a primary energy source depending on the state of feeding or fasting. In insulin resistance, this flexibility is impaired, favouring carbohydrate oxidation even during fasting states (Ukropcova et al., 2007). This not only reduces fat oxidation but also leads to an energy imbalance where the body constantly craves glucose, reinforcing overeating behaviour and perpetuating fat storage.

4. Increased Inflammatory Signalling

Chronic low-grade inflammation is a hallmark of insulin resistance and metabolic syndrome. Pro-inflammatory cytokines such as TNF-α and IL-6 interfere with insulin signalling pathways and contribute to the dysregulation of adipokines—hormones secreted by fat tissue that regulate appetite, glucose metabolism, and fat distribution (Hotamisligil, 2006). Inflammation impairs mitochondrial function, further reducing metabolic efficiency and fat oxidation, making weight loss more difficult (Furukawa et al., 2004).

5. Basal Metabolic Rate (BMR) Reductions

Some studies suggest that insulin resistance may be associated with reduced resting energy expenditure. While more research is needed, it is hypothesised that chronic hyperinsulinaemia, mitochondrial dysfunction, and inflammation all contribute to a lower-than-expected metabolic rate, which may reduce the effectiveness of standard calorie restriction strategies (Petersen et al., 2003).

Dietary and Lifestyle Solutions

While insulin resistance makes weight loss more challenging, it is not insurmountable. The key lies in strategies that improve insulin sensitivity while creating a sustainable caloric deficit.

Low Glycemic and Low-Carbohydrate Diets

Numerous studies have demonstrated the benefits of reducing dietary carbohydrate intake, particularly refined and high glycemic sources, in improving insulin sensitivity and facilitating weight loss. Low-carbohydrate diets have been shown to reduce insulin levels, promote fat oxidation, and lead to greater fat loss compared to high-carbohydrate diets in insulin-resistant populations (Saslow et al., 2017; Ludwig et al., 2018).

Time-Restricted Feeding and Intermittent Fasting

Time-restricted feeding (TRF) and intermittent fasting (IF) have shown promise in reducing insulin levels and improving metabolic flexibility. By extending the fasting window and reducing postprandial insulin spikes, these approaches can enhance fat mobilisation and improve weight loss outcomes in insulin-resistant individuals (Patterson and Sears, 2017).

Physical Activity

Exercise, particularly resistance and high-intensity interval training (HIIT), has a significant impact on improving insulin sensitivity. Muscle contractions during exercise facilitate glucose uptake independently of insulin, thereby improving glucose control and reducing the insulin burden (Hawley and Lessard, 2008). Regular exercise also enhances mitochondrial function and promotes a favourable shift in body composition.

Sleep and Stress Management

Poor sleep and chronic stress can worsen insulin resistance by increasing cortisol, disrupting circadian rhythms, and promoting inflammation (Spiegel et al., 2005). Lifestyle interventions that prioritise adequate sleep and stress reduction, such as mindfulness, meditation, and structured sleep hygiene, should be core components of any weight loss program for individuals with insulin resistance.

Conclusion

Insulin resistance represents a significant barrier to effective weight loss due to its multifactorial impact on metabolism, appetite regulation, fat storage, and energy utilisation. It alters the body’s hormonal environment in ways that favour fat retention and inhibit fat mobilisation, making traditional weight loss strategies less effective. However, with targeted dietary and lifestyle interventions that aim to restore insulin sensitivity, individuals can overcome these challenges and achieve sustainable fat loss.

Understanding the root cause—insulin dysfunction—empowers individuals and practitioners to take a more personalised, physiology-informed approach to weight management. The journey may be more complex, but with the right tools, it is entirely achievable.

References

Benedict, C., Kern, W., Born, J. and Hallschmid, M., 2003. Central nervous insulin action regulates food intake. The Journal of Clinical Investigation, 112(4), pp.522–529.

Boden, G., 2008. Obesity and free fatty acids. Endocrinology and Metabolism Clinics, 37(3), pp.635–646.

Czech, M.P., 2017. Insulin action and resistance in obesity and type 2 diabetes. Nature Medicine, 23(7), pp.804–814.

Després, J.P., 2012. Body fat distribution and risk of cardiovascular disease: an update. Circulation, 126(10), pp.1301–1313.

Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M. and Shimomura, I., 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation, 114(12), pp.1752–1761.

Hawley, J.A. and Lessard, S.J., 2008. Exercise training-induced improvements in insulin action. Acta Physiologica, 192(1), pp.127–135.

Hotamisligil, G.S., 2006. Inflammation and metabolic disorders. Nature, 444(7121), pp.860–867.

Kashyap, S.R. and DeFronzo, R.A., 2007. The insulin resistance syndrome: physiological considerations. Diabetes Care, 30(2), pp.169–173.

Ludwig, D.S., Ebbeling, C.B., et al., 2018. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. BMJ, 363, p.k4583.

Myers, M.G., Cowley, M.A. and Münzberg, H., 2010. Mechanisms of leptin action and leptin resistance. Annual Review of Physiology, 70, pp.537–556.

Patterson, R.E. and Sears, D.D., 2017. Metabolic effects of intermittent fasting. Annual Review of Nutrition, 37, pp.371–393.

Petersen, K.F. and Shulman, G.I., 2018. Mechanisms of insulin action and insulin resistance. Physiological Reviews, 98(4), pp.2133–2223.

Petersen, K.F., Dufour, S. and Shulman, G.I., 2003. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Medicine, 1(3), p.e69.

Saslow, L.R., Mason, A.E., Kim, S., et al., 2017. An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: a randomized controlled trial. Journal of Medical Internet Research, 19(2), p.e36.

Spiegel, K., Leproult, R. and Van Cauter, E., 2005. Impact of sleep debt on metabolic and endocrine function. The Lancet, 354(9188), pp.1435–1439.

Ukropcova, B., McNeil, M., Sereda, O., De Jonge, L., Xie, H., Bray, G.A. and Smith, S.R., 2007. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. The Journal of Clinical Investigation, 117(10), pp.3093–3101.